You are here: Industry Insights > vaccines

News List

mRNA Technology for Vaccines and Broader Applications Saher Haider
May 06, 2025
Messenger RNA (mRNA) Technology has swiftly made its way to the field of vaccinology, offering a novel approach to immunization that differs fundamentally from traditional mechanisms of vaccination.
Personalized Vaccines: How Neoantigens Are Changing Cancer Immunotherapy Nurah Ekhlaque
April 07, 2025
Explore how neoantigen-based vaccines are revolutionizing cancer immunotherapy by enabling personalized, targeted treatment strategies for better outcomes.
Current Status of Research and Application of Preventive Human Papillomavirus (HPV) Vaccines Xiaomichong
July 23, 2024
In recent years, the topic of "HPV vaccine" has maintained a high level of attention, with netizens complaining about the difficulty of obtaining a vaccine.
Research Progress on Therapeutic Human Papillomavirus (HPV) Vaccines Xiaomichong
July 23, 2024
Currently, the research and development technology for prophylactic human papillomavirus (HPV) vaccines is becoming increasingly mature (related reading: "Current Status of Research and Application of Prophylactic Human Papillomavirus (HPV) Vaccines").
The Growth of Vaccines Beyond Infectious Disease Suzanne Elvidge
April 19, 2024
Vaccination for infectious diseases saves two to three million lives a year worldwide, according to the World Health Organization (WHO).
Breakthroughs in Melanoma Immunotherapy & RNA Vaccines Daivd Orchard Webb/PharmaSources
July 03, 2023
Melanoma is a type of skin cancer that develops from pigment-producing cells called melanocytes.
New Improvement in Universal Vaccines and Long-acting Neutralizing Antibodies PharmaSources/Yefenghong
May 25, 2022
COVID-19 has spread rapidly since the winter of 2019, and even today, the whole world is still shrouded in its haze.
Money and Myths Surrounding the COVID-19 Vaccines PharmaSources/Nik Patel
December 02, 2021
Covid vaccines have demonstrated themselves to be highly effective, reducing the need for hospitalisation and risk of death by a massive 95%.
Demand for High-End COVID-19 Vaccines to Drive Growth of Excipients Market SHEM OIRERE
December 17, 2021
The COVID-19 pandemic has infected 247 million people and killed five million others as of November 01, 2021 the situation still looks grim due to the high infection rates, the prolonged SARS-CoV-2 virus...
Where Are the Oral COVID-19 Vaccines Stand Now? Lin Zhang
December 17, 2021
The novel coronavirus, SARS-CoV-2, has led to an unprecedented international health crisis and is continuing its spread across the world, with more than 218 million confirmed cases of COVID-19, including more than 4.5 million deaths, reported to the WHO a